98%
921
2 minutes
20
Goal: African Americans lack participation in clinical trials, and therefore, are underrepresented in medical initiatives that can provide life-saving treatment. This research examines the attitudes, beliefs, and perceptions of African Americans toward participation in clinical trials.
Methods: Researchers conducted a survey using a representative sample of African Americans in the United States (n = 1,260). Structural equation modeling was used to analyze the data.
Principal Findings: Findings indicate that behavioral beliefs about clinical trials are positively related to attitudes about participating in clinical trials. Furthermore, attitudes are positively related to intentions to participate in clinical trials. Participation in clinical trials is also dictated by social influence. Results indicate that what "important others" think about participation in clinical trials is positively related to trial participation; however, risk perceptions are negatively related to trial participation. Findings reveal that gender and educational attainment moderate risk perceptions. African American women and those with less educational attainment possess risk perceptions, which negatively influence their intention to participate in clinical trials.
Practical Applications: This research highlights how behavioral beliefs and attitudes are positively linked to participation intentions, while subjective norms further reinforce the influence of social pressures on decision-making. Importantly, risk perceptions serve as a significant barrier to participation, particularly among African American women and individuals with lower educational attainment. These findings point to the need for targeted interventions that address specific concerns and build trust through culturally informed, accessible communication. By developing communication strategies that enhance positive beliefs, leverage community influence, and reduce perceived risks, research and healthcare communities can take meaningful steps toward fostering inclusion and trust.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/JHM-D-24-00137 | DOI Listing |
Infect Dis Ther
September 2025
School of Biomedical Sciences, The Chinese University of Hong Kong (CUHK), Hong Kong SAR, China.
Introduction: The high mortality of Coronavirus Disease 2019 (COVID-19) highlights the need for safe and effective antiviral treatment. Small molecular antivirals (remdesivir, molnupiravir, nirmatrelvir/ritonavir) and immunomodulators (baricitinib, tocilizumab) have been developed or repurposed to suppress viral replication and ameliorate cytokine storms, respectively. Despite U.
View Article and Find Full Text PDFJ Neurooncol
September 2025
Institute of Medical Biostatistics, Epidemiology, and Informatics (IMBEI), University Medical Center Mainz, Mainz, Germany.
Purpose: Patients diagnosed with high-grade gliomas (HGG) often experience substantial psychosocial dis-tress. However, due to neurological and neurocognitive deficits its assessment remains challenging, and needs remain unmet. We compared a novel face-to-face assessment during doctor-patient conversations with questionnaire-based screening.
View Article and Find Full Text PDFCancer Immunol Immunother
September 2025
Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Whole blood (WB) transcriptomics offers a minimal-invasive method to assess patients' immune system. This study aimed to identify transcriptional patterns in WB associated with clinical outcomes in patients treated with immune checkpoint inhibitors (ICIs). We performed RNA-sequencing on pre-treatment WB samples from 145 patients with advanced cancer.
View Article and Find Full Text PDFNat Genet
September 2025
Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Aberrant DNA methylation has been described in nearly all human cancers, yet its interplay with genomic alterations during tumor evolution is poorly understood. To explore this, we performed reduced representation bisulfite sequencing on 217 tumor and matched normal regions from 59 patients with non-small cell lung cancer from the TRACERx study to deconvolve tumor methylation. We developed two metrics for integrative evolutionary analysis with DNA and RNA sequencing data.
View Article and Find Full Text PDFNat Rev Neurol
September 2025
Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.
Health disparities are preventable differences in health between different populations, and they are endemic throughout medicine owing to social, economic and environmental disadvantages. Neurology is no exception, and health disparities for systematically marginalized groups are present in the prevention, diagnosis, treatment and outcomes of all neurological disorders. The aetiology of these disparities is complex and multifactorial, reflecting the interplay of structural, institutional and individual-level factors.
View Article and Find Full Text PDF